Literature DB >> 11454014

Variation at the cholesteryl ester transfer protein gene in relation to plasma high density lipoproteins cholesterol levels and carotid intima-media thickness.

S Kakko1, M Tamminen, M Päivänsalo, H Kauma, A O Rantala, M Lilja, A Reunanen, Y A Kesäniemi, M J Savolainen.   

Abstract

BACKGROUND: Cholesteryl ester transfer protein (CETP) plays a major role in lipoprotein metabolism. We have screened the CETP gene for mutations and polymorphisms regulating high density lipoproteins cholesterol (HDL-C) levels and the development of atherosclerosis, and found some polymorphisms (I405V and R451Q) to have minor effects.
DESIGN: The purpose of this study was to investigate the combined effect of the several polymorphisms of the CETP gene so far found on HDL-C levels and carotid intima-media thickness (IMT), and, in addition, to study whether the recently found functional polymorphism in the promoter region of the CETP gene (C to A, - 629 relative to the first transcribed nucleotide) explains the previous associations due to linkage disequilibrium. The genotypes were determined in a population sample of 481 men and women.
RESULTS: There were no significant differences in plasma CETP activity or carotid IMT between the genotypes of the promoter polymorphism. The women with the CC genotype of the promoter polymorphism had the lowest HDL-C levels (P < 0.001), but no such difference was seen in men. Detected polymorphisms of the CETP gene explained about 8% of the variation in HDL-C in women and about 7 and 10% of the variation in carotid IMT in women and men, respectively. The associations of the promoter, I405V and R451Q-A373P polymorphisms with HDL-C and carotid IMT seemed to be independent of each other. The associations with IMT were independent of total HDL-C levels, suggesting that HDL subfractions may have more effect on IMT.
CONCLUSION: The CETP gene locus was found to be polymorphic and its polymorphisms explained a reasonable proportion of the variation in the degree of carotid atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11454014     DOI: 10.1046/j.1365-2362.2001.00859.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  13 in total

Review 1.  Genetics and personalized medicine--a role in statin therapy?

Authors:  Jaideep Patel; Thura Abd; Roger S Blumenthal; Khurram Nasir; H Robert Superko
Journal:  Curr Atheroscler Rep       Date:  2014-01       Impact factor: 5.113

2.  Association of cholesteryl ester transfer protein (TaqIB) and apolipoprotein E (HhaI) gene variants with obesity.

Authors:  Neena Srivastava; B R Achyut; Jai Prakash; C G Agarwal; D C Pant; Balraj Mittal
Journal:  Mol Cell Biochem       Date:  2008-05-04       Impact factor: 3.396

3.  Cholesteryl ester transfer protein gene haplotypes, plasma high-density lipoprotein levels and the risk of coronary heart disease.

Authors:  Pamela A McCaskie; John P Beilby; Caroline M L Chapman; Joseph Hung; Brendan M McQuillan; Peter L Thompson; Lyle J Palmer
Journal:  Hum Genet       Date:  2007-02-08       Impact factor: 4.132

4.  Associations of genetic variants in ATP-binding cassette A1 and cholesteryl ester transfer protein and differences in lipoprotein subclasses in the multi-ethnic study of atherosclerosis.

Authors:  Michael Y Tsai; Na Li; A Richey Sharrett; Steven Shea; David R Jacobs; Russell Tracy; Donna Arnett; Valerie Arends; Wendy Post
Journal:  Clin Chem       Date:  2009-01-08       Impact factor: 8.327

5.  Cholesteryl ester transfer protein (CETP) genetic variation and early onset of non-fatal myocardial infarction.

Authors:  V Meiner; Y Friedlander; H Milo; N Sharon; L Ben-Avi; S Shpitzen; E Leitersdorf; D S Siscovick; S M Schwartz
Journal:  Ann Hum Genet       Date:  2008-07-15       Impact factor: 1.670

Review 6.  Review of the cost effectiveness of pharmacogenetic-guided treatment of hypercholesterolaemia.

Authors:  Michael J Sorich; Michael D Wiese; Rebekah L O'Shea; Brita Pekarsky
Journal:  Pharmacoeconomics       Date:  2013-05       Impact factor: 4.981

7.  Cholesteryl ester transfer protein genetic polymorphisms, HDL cholesterol, and subclinical cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis.

Authors:  Michael Y Tsai; Craig Johnson; W H Linda Kao; A Richey Sharrett; Valerie L Arends; Richard Kronmal; Nancy Swords Jenny; David R Jacobs; Donna Arnett; Daniel O'Leary; Wendy Post
Journal:  Atherosclerosis       Date:  2008-02-20       Impact factor: 5.162

8.  Association of CETP TaqI and APOE polymorphisms with type II diabetes mellitus in North Indians: a case control study.

Authors:  Manjusha Dixit; Sandeep Bhattacharya; Balraj Mittal
Journal:  BMC Endocr Disord       Date:  2005-07-01       Impact factor: 2.763

9.  Association of CETP Taq1B and -629C > A polymorphisms with coronary artery disease and lipid levels in the multi-ethnic Singaporean population.

Authors:  Yongjian Lu; Naeimeh Tayebi; Hongzhe Li; Nilmani Saha; Hongyuan Yang; Chew-Kiat Heng
Journal:  Lipids Health Dis       Date:  2013-06-08       Impact factor: 3.876

10.  Effect of Synthetic Truncated Apolipoprotein C-I Peptide on Plasma Lipoprotein Cholesterol in Nonhuman Primates.

Authors:  Rampratap S Kushwaha; Henry C McGill; Frederick H Hausheer
Journal:  J Biomed Biotechnol       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.